News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
Patient & Donor Stories, Research
Nussbaum family fuels pancreatic cancer research
When Sam Nussbaum was diagnosed with pancreatic cancer in his 70s, it was no surprise to his family that he chose WashU Medicine for his care. After all, Nussbaum had spent a significant portion of his distinguished career as a physician-scientist and health-care executive at the medical school and BJC HealthCare. And during that time, […]
In the Media, Research, Staff/Faculty Update
Puram Elected to American Society for Clinical Investigation
Sidharth (Sid) V. Puram, MD, PhD, co-director of The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center at Siteman Cancer Center, has been elected to the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected medical honor societies. Siteman is based at Barnes-Jewish Hospital and WashU Medicine, where Puram also is the Lindburg Professor and chair of the Department of […]
In the Media, Research, Staff/Faculty Update
Grants Bolster Research on Myelodysplastic Syndromes
Foundation awards $1.5 million total in grants to WashU Medicine researchers at Siteman Cancer Center to advance precision diagnosis and treatment for patients with myelodysplastic syndromes The Edward P. Evans Foundation has awarded separate three-year Discovery Research Grants to Jeremy Baeten, PhD, an assistant professor of medicine, and Matthew Walter, MD, the Edward P. Evans Endowed Professor of Myelodysplastic […]
In the Media, Research, Staff/Faculty Update
Siteman Cancer Center Prevention Expert Named Guggenheim Fellow
With the prestigious award, Yin Cao, ScD, MPH, will write a book examining why cancers are increasingly occurring earlier in life — and how this shift can be better understood, communicated and prevented. Yin Cao, ScD, MPH, has been named a 2026 Fellow of the John Simon Guggenheim Memorial Foundation, one of the nation’s most prestigious […]
In the Media, Research, Staff/Faculty Update
Siteman Catalyst Awards Support Groundbreaking Science
Four researchers receive new funding to explore brain‑sparing radiation, smarter leukemia drugs, better BRCA1 risk prediction and new strategies against aggressive pancreatic cancer Four WashU Medicine researchers at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, have received Siteman Catalyst Awards to pursue innovative ideas that could change how cancers are detected and treated. Each awardee is receiving $100,000 […]
In the Media, Research
mRNA Technology Opens Doors for Potential New Ways of Preventing and Treating Cancer
WashU Medicine researchers at Siteman Cancer Center are leading next-generation cancer vaccine development. The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel-prize–winning technology is being adapted to fight cancer, with mRNA vaccines in clinical trials for melanoma, small cell lung cancer and bladder cancer, among […]
In the Media, Research, Staff/Faculty Update
Siteman Cancer Center Experts to be Recognized, Present Key Research at AACR Annual Meeting
Two WashU Medicine physician-scientists will be honored, and 30 faculty members and others will present findings at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. At the American Association for Cancer Research (AACR) Annual Meeting 2026, WashU Medicine scientists and physician-researchers at Siteman Cancer Center are demonstrating […]
Clinical, In the Media, Research
Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery
WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, researchers have identified a malignant cell biomarker that may predict which patients will respond to the […]
Clinical, In the Media, Research
Innovative CAR-T cell therapy receives FDA breakthrough therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this […]
In the Media, Research, Staff/Faculty Update
Grant furthers novel therapeutic approach to glioblastoma
Mosquito-borne Zika virus helps destroy deadly brain cancer in mice Milan G. Chheda, MD, an associate professor of medicine in the Division of Oncology at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, […]